Abstract:Randomised trials (also referred to as 'randomised controlled trials' or 'trials') are the optimal way to minimise bias in evaluating the effects of competing treatments, therapies and innovations in health care. It is important to achieve the required sample size for a trial, otherwise trialists may not be able to draw conclusive results leading to research waste and raising ethical questions about trial participation. The reasons why potential participants may accept or decline participation are multifaceted. Yet, the evidence of effectiveness of interventions to improve recruitment to trials is not substantial and fails to recognise these individual decision‐making processes. It is important to synthesise the experiences and perceptions of those invited to participate in randomised trials to better inform recruitment strategies. To explore potential trial participants' views and experiences of the recruitment process for participation. The specific objectives are to describe potential participants' perceptions and experiences of accepting or declining to participate in trials, to explore barriers and facilitators to trial participation, and to explore to what extent barriers and facilitators identified are addressed by strategies to improve recruitment evaluated in previous reviews of the effects of interventions including a Cochrane Methodology Review. We searched the Cochrane Library, Medline, Embase, CINAHL, Epistemonikos, LILACS, PsycINFO, ORRCA, and grey literature sources. We ran the most recent set of searches for which the results were incorporated into the review in July 2017. We included qualitative and mixed‐methods studies (with an identifiable qualitative component) that explored potential trial participants' experiences and perceptions of being invited to participate in a trial. We excluded studies that focused only on recruiters' perspectives, and trials solely involving children under 18 years, or adults who were assessed as having impaired mental capacity. Five review authors independently assessed the titles, abstracts and full texts identified by the search. We used the CART (completeness, accuracy, relevance, timeliness) criteria to exclude studies that had limited focus on the phenomenon of interest. We used QSR NVivo to extract and manage the data. We assessed methodological limitations using the Critical Skills Appraisal Programme (CASP) tool. We used thematic synthesis to analyse and synthesise the evidence. This provided analytical themes and a conceptual model. We used the GRADE‐CERQual (Confidence in the Evidence from Reviews of Qualitative research) approach to assess our confidence in each finding. Our findings were integrated with two previous intervention effectiveness reviews by juxtaposing the quantitative and qualitative findings in a matrix. We included 29 studies (published in 30 papers) in our synthesis. Twenty‐two key findings were produced under three broad themes (with six subthemes) to capture the experience of being invited to participate in a trial and making the decision whether to participate. Most of these findings had moderate to high confidence. We identified factors from the trial itself that influenced participation. These included how trial information was communicated, and elements of the trial such as the time commitment that might be considered burdensome. The second theme related to personal factors such as how other people can influence the individual's decision; and how a personal understanding of potential harms and benefits could impact on the decision. Finally, the potential benefits of participation were found to be key to the decision to participate, namely personal benefits such as access to new treatments, but also the chance to make a difference and help others. The conceptual model we developed presents the decision‐making process as a gauge and the factors that influence whether the person will, or will not, take part. This qualitative evidence synthesis has provided comprehensive insight into the complexity of factors that influence a person's decision whether to participate in a trial. We developed key questions that trialists can ask when developing their recruitment strategy. In addition, our conceptual model emphasises the need for participant‐centred approaches to recruitment. We demonstrated moderate to high level confidence in our findings, which in some way can be attributed to the large volume of highly relevant studies in this field. We recommend that these insights be used to direct or influence or underpin future recruitment strategies that are developed in a participant‐driven way that ultimately improves trial conduct and reduces research waste. What is the aim of this review? Randomised trials are needed for understanding if and how different healthcare interventions (such as medicines, types of surgeries, health promotion activities, etc.) work or not. Getti -Abstract Truncated-

Study design factors influencing patients’ willingness to participate in clinical research: a randomised vignette-based study

[Patients' Predisposition to Participate in Clinical Trials at Hospital: A Cross-Sectional Study]

Sociodemographic and psychological characteristics influencing patients’ willingness to participate in clinical trials

Prevalence Survey of Cognition of Potential Participants for Clinical Trials

Factors Influencing Willingness to Participate in Clinical Studies in Pediatric Anesthesia (FILIPPA): A vignette-based, structured interview study

The attitudes of 1066 patients with cancer towards participation in randomised clinical trials

COVID-19 clinical trials: who is likely to participate and why?

How do study design features and participant characteristics influence willingness to participate in clinical trials? Results from a choice experiment

[The patient in clinical research: disposable guinea pig or involved actor?]

What do medical students think of own participation as subjects in clinical trials?

P952 Why do patients with Inflammatory Bowel Disease Take Part in Pharmaceutical Clinical Trials? A qualitative study of Clinical Trial Participants

Patient distrust in pharmaceutical companies: an explanation for women under-representation in respiratory clinical trials?

Aversion to pragmatic randomised controlled trials: three survey experiments with clinicians and laypeople in the USA

Analysis of Influencing Factors and Countermeasures of Public Participation in Drug Clinical Trials

Attitudes on participation in clinical drug trials: A nationally representative survey of older adults with multimorbidity

Factors influencing willingness to participate in ophthalmic clinical trials and strategies for effective recruitment

Primary care physicians and laypersons' perceptions of multicancer detection clinical trial designs

Investigation on the Willingness to Participate in Clinical Trials of Cancer Patients and Related Factors

What motivates SARS-CoV-2 vaccine trial participants? A pre- and post-participation survey study

Women and willingness to participate in clinical trials: results from a hypothetical randomized control trial

Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis.